Chemours Co. Files 8-K on Shareholder Vote Matters

Ticker: CC · Form: 8-K · Filed: 2025-04-24T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

TL;DR

Chemours is putting key decisions to a shareholder vote, expect news soon.

AI Summary

On April 22, 2025, The Chemours Company filed an 8-K report detailing a submission of matters to a vote of its security holders. The filing, made on April 24, 2025, indicates that important corporate decisions requiring shareholder approval were presented.

Why It Matters

This filing signals that Chemours is seeking shareholder approval for significant corporate actions, which could impact the company's strategic direction and shareholder rights.

Risk Assessment

Risk Level: low — The filing is a standard procedural report regarding shareholder votes and does not inherently indicate financial distress or significant operational changes.

Key Players & Entities

FAQ

What specific matters were submitted for a vote of Chemours' security holders?

The filing states that it is a 'Submission of Matters to a Vote of Security Holders,' but the specific details of these matters are not elaborated upon in the provided excerpt.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on April 22, 2025.

What is the principal executive office address for The Chemours Company?

The principal executive offices are located at 1007 Market Street, Wilmington, Delaware 19801.

What is Chemours Company's IRS Employer Identification Number (EIN)?

The EIN for The Chemours Company is 46-4845564.

Under which section of the Securities Exchange Act of 1934 is this report filed?

This is a Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

From the Filing

0000950170-25-058126.txt : 20250424 0000950170-25-058126.hdr.sgml : 20250424 20250424163630 ACCESSION NUMBER: 0000950170-25-058126 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20250422 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20250424 DATE AS OF CHANGE: 20250424 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 25867897 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 8-K 1 cc-20250422.htm 8-K 8-K 0001627223 false 0001627223 2025-04-22 2025-04-22     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   April 22, 2025 Date of Report (Date of Earliest Event Reported) The Chemours Company (Exact Name of Registrant as Specified in Its Charter)   Delaware   001-36794   46-4845564 (State or Other Jurisdiction   (Commission   (I.R.S. Employer Of Incorporation)   File Number)   Identification No.)   1007 Market Street Wilmington , Delaware 19801 (Address of principal executive offices)   Registrant’s telephone number, including area code: (302) 773-1000   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of Each Class   Trading Symbol(s)   Name of Exchange on Which Registered Common Stock ($0.01 par value)   CC   New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐             Item 5.07 Submission of Matters to a Vote of Security Holders. The Chemours Company (the “Company”) held its annual meeting of shareholders on April 22, 2025 (the “Annual Meeting”). At the Annual Meeting, shareholders: • elected all twelve director nominees to serve a one-year term; • approved the Company’s annual “say-on-pay” vote on an advisory basis; • ratified the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm; • voted below the eighty percent (80%) threshold needed to approve amendments to the Company’s Amended and Restated Certificate of Incorporation to eliminate supermajority voting provisions with respect to

View on Read The Filing